130 related articles for article (PubMed ID: 2280827)
1. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
Azorin JM; Raucoules D; Valli M; Levy C; Lancon C; Luccioni JM; Tissot R
Neuropsychobiology; 1990; 23(1):18-24. PubMed ID: 2280827
[TBL] [Abstract][Full Text] [Related]
2. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
[TBL] [Abstract][Full Text] [Related]
3. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
Roy A; Jimerson DC; Pickar D
Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
[TBL] [Abstract][Full Text] [Related]
4. Noradrenergic function and the dexamethasone suppression test in depression.
Morinobu S; Satoh H; Endoh M; Totsuka S
Jpn J Psychiatry Neurol; 1987 Dec; 41(4):669-76. PubMed ID: 3453415
[TBL] [Abstract][Full Text] [Related]
5. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?
Halbreich U; Sharpless N; Asnis GM; Endicott J; Goldstein S; Vital-Herne J; Eisenberg J; Zander K; Kang BJ; Shindledecker R
Arch Gen Psychiatry; 1987 Sep; 44(9):804-12. PubMed ID: 3632254
[TBL] [Abstract][Full Text] [Related]
6. The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients.
Karege F; Bovier P; Gaillard JM; Tissot R
Acta Psychiatr Scand; 1989 Nov; 80(5):499-504. PubMed ID: 2596350
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma MHPG in dexamethasone-resistant depressed patients.
Jimerson DC; Insel TR; Reus VI; Kopin IJ
Arch Gen Psychiatry; 1983 Feb; 40(2):173-6. PubMed ID: 6824413
[TBL] [Abstract][Full Text] [Related]
8. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
Trestman RL; Lawrence TL; Coccaro EF; Harvey P; Bernstein D; Lawrence EK; Condello V; Mahon T; Yang RK; Knott P
Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
[TBL] [Abstract][Full Text] [Related]
9. Plasma 3-methoxy-4-hydroxyphenylglycol in manic patients: relationships with clinical variables.
Azorin JM; Pupeschi G; Valli M; Joanny P; Raucoules D; Lancon C; Tissot R
Acta Psychiatr Scand; 1990 Jan; 81(1):14-8. PubMed ID: 2330823
[TBL] [Abstract][Full Text] [Related]
10. Apparent phase advance in diurnal MHPG rhythm in depression.
Gwirtsman HE; Halaris AE; Wolf AW; DeMet E; Piletz JE; Marler M
Am J Psychiatry; 1989 Nov; 146(11):1427-33. PubMed ID: 2817113
[TBL] [Abstract][Full Text] [Related]
11. Disruption of circadian MHPG rhythmicity in major depression.
Piletz JE; DeMet E; Gwirtsman HE; Halaris A
Biol Psychiatry; 1994 Jun; 35(11):830-42. PubMed ID: 8054405
[TBL] [Abstract][Full Text] [Related]
12. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
Holsboer F; Haack D; Gerken A; Vecsei P
Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
Zhou DF; Shen YC; Shu LN; Lo HC
Biol Psychiatry; 1987 Jul; 22(7):883-91. PubMed ID: 3607115
[TBL] [Abstract][Full Text] [Related]
14. Urinary MHPG in subgroups of depressed patients and normal controls.
Beckmann H; Goodwin FK
Neuropsychobiology; 1980; 6(2):91-100. PubMed ID: 7354911
[TBL] [Abstract][Full Text] [Related]
15. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
[TBL] [Abstract][Full Text] [Related]
16. Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients.
Trestman RL; Yehuda R; Coccaro E; Horvath T; Knott P; Gabriel S; Siever LJ
Biol Psychiatry; 1995 Apr; 37(7):448-56. PubMed ID: 7786958
[TBL] [Abstract][Full Text] [Related]
17. Depression and dexamethasone suppression testing in children and adolescents.
Emslie GJ; Weinberg WA; Rush AJ; Weissenburger J; Parkin-Feigenbaum L
J Child Neurol; 1987 Jan; 2(1):31-7. PubMed ID: 3624827
[TBL] [Abstract][Full Text] [Related]
18. Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients.
Cooke RG; Warsh JJ; Stancer HC; Hasey GM; Jorna T; Langlet F
Can J Psychiatry; 1990 Feb; 35(1):31-5. PubMed ID: 2317731
[TBL] [Abstract][Full Text] [Related]
19. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
Ko HC; Lu RB; Shiah IS; Hwang CC
Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
[TBL] [Abstract][Full Text] [Related]
20. Platelet 5-HT and plasma MHPG levels in patients with bipolar I and bipolar II depressions and normal controls.
Shiah IS; Ko HC; Lee JF; Lu RB
J Affect Disord; 1999; 52(1-3):101-10. PubMed ID: 10357023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
